| Tara Renee Soth, MS, CCC-SLP | |
|
5900 Metro Dr, Baltimore, MD 21215-3207 | |
| (410) 318-6780 | |
| (410) 318-6759 |
| Full Name | Tara Renee Soth |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5900 Metro Dr, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013199967 | NPI | - | NPPES |
| 883994-02 | Other | MD | CARE FIRST BCBS |
| J175-0024 | Other | DC | CAREFIRST BCBS |
| 883994-01 | Other | MD | CAREFIRST BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 04017 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tara Renee Soth, MS, CCC-SLP 5900 Metro Dr, Baltimore, MD 21215-3207 Ph: (410) 318-6780 | Tara Renee Soth, MS, CCC-SLP 5900 Metro Dr, Baltimore, MD 21215-3207 Ph: (410) 318-6780 |
News Archive
An experimental hepatitis B drug has earned the praise of US health experts for its effectiveness and has been recommended by the US Food and Drug Administration (FDA) advisory panel to treat the liver disease in adults.
Self-injury so often occurs in private, an important reason why solid statistics are hard to come by. But researchers estimate between 10 and 40 percent of adolescents, and up to 10 percent of adults, harm themselves physically - usually by cutting or burning their skin.
A team of researchers wanted to investigate whether timing, number, and frequency of brain-stimulating activities in midlife and late life are linked to the risk of incident mild cognitive impairment (MCI).
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
Young adults who had chemotherapy as a child have decreased cognitive flexibility and a weaker short-term memory.
› Verified 3 days ago
Mrs. Megan Nese, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3138 Fait Ave, Baltimore, MD 21224 Phone: 410-325-4000 | |
Mrs. Chaya Brenner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6414 Park Hts, Suite T1, Baltimore, MD 21215 Phone: 410-318-8561 Fax: 866-840-6040 | |
Ms. Holly Fredrickson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3855 Greenspring Ave, Baltimore, MD 21211 Phone: 410-225-9160 | |
Emily Kathryn Dreschel, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 707 N Broadway, Baltimore, MD 21205 Phone: 443-923-1872 | |
Miss Chaya Rachel Segel, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Church Ln Ste 203, Baltimore, MD 21208 Phone: 410-849-9496 | |
Rachel Weeks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 S Patterson Park Ave Apt 4, Baltimore, MD 21231 Phone: 443-520-5758 | |
Ms. Laura Ashley Classick, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6600 Ridge Rd, Baltimore, MD 21237 Phone: 410-574-4950 |